Code | 51504 | ||||||||||
MA number | EU/1/07/427/047 | ||||||||||
Product Form: | tbl oro 35x20 mg (blis.OPA/Al/PVC/Al) | ||||||||||
MA Status: | E - Valid centralised marketing authorisation | ||||||||||
Type of procedure: | EU | ||||||||||
MAH, country: | Teva B.V., Netherland | ||||||||||
Therapeutic Class: | 68 - ANTIPSYCHOTICA (NEUROLEPTICA) | ||||||||||
ATC: |
|
||||||||||
Shelf life: | 24 | ||||||||||
Container: | blister OPA/Al/PVC/Al | ||||||||||
Route of admin.: | Oral use |
Prescription Status: | Medicinal product subject to medical prescription. |
Legal basis: | Article 10(1) generic application |
MA issued: | 12.12.2007 |
SmPC + PL: |
|
Safety feature | Yes |
Data update: | 19.06.2018 |